Published in J Neurol on April 01, 2003
Levetiracetam in the treatment of vascular chorea: a case report. Eur J Clin Pharmacol (2004) 1.40
Irreversible Hemichorea-Hemiballism in a Case of Nonketotic Hyperglycemia Presenting as the Initial Manifestation of Diabetes Mellitus. Tremor Other Hyperkinet Mov (N Y) (2016) 0.99
Chorea and related disorders. Postgrad Med J (2004) 0.99
Hypoglycemia-induced hemichorea in a patient with Fahr's syndrome. Neurol Sci (2012) 0.90
Hemichorea hemiballism syndrome: the first presentation of type 2 diabetes mellitus as a rare cause of chorea. Iran J Radiol (2011) 0.85
Giant middle fossa epidermoid presenting as holmes' tremor syndrome. J Mov Disord (2014) 0.85
A case of moyamoya disease presenting with chorea. Childs Nerv Syst (2005) 0.81
Chorea as the first sign in a patient with elderly-onset systemic lupus erythematosus. Case Rep Neurol Med (2012) 0.77
Drug-induced hemichorea. BMJ Case Rep (2015) 0.75
Acute hemichorea-hemiballism as a sole manifestation of acute thalamic infarct: An unusual occurrence. J Neurosci Rural Pract (2016) 0.75
Reply #2 to: Glycemic Choreoballism. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75
Hemiballistic movements in a newly HIV patient. IDCases (2016) 0.75
Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke (2006) 2.11
Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain (2008) 1.63
A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol (2003) 1.49
Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy. Neurol Sci (2012) 1.39
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol (2012) 1.34
Huntington's disease: the current state of research with peripheral tissues. Exp Neurol (2009) 1.32
Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain (2003) 1.26
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord (2008) 1.06
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics (2005) 1.06
Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev (2005) 1.00
The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet (2004) 0.99
Irreversible apnoeic coma 35 years later. Towards a more rigorous definition of brain death? Intensive Care Med (2004) 0.99
Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients. J Neurol (2007) 0.92
Analysis of ferritin genes in Parkinson disease. Clin Chem Lab Med (2007) 0.89
Aberrant A2A receptor function in peripheral blood cells in Huntington's disease. FASEB J (2003) 0.89
ICF in neurology: functioning and disability in patients with migraine, myasthenia gravis and Parkinson's disease. Disabil Rehabil (2009) 0.87
Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology (2005) 0.87
In vivo evidence for GABA(A) receptor changes in the sensorimotor system in primary dystonia. Mov Disord (2011) 0.87
Impaired awareness of movement disorders in Parkinson's disease. Brain Cogn (2009) 0.86
Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease. Parkinsonism Relat Disord (2008) 0.85
Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. J Neurol (2013) 0.84
Case 159: cerebral amyloid angiopathy-related inflammation. Radiology (2010) 0.84
Interhemispheric balance in Parkinson's disease: a transcranial magnetic stimulation study. Brain Stimul (2013) 0.83
Disability and profiles of functioning of patients with Parkinson's disease described with ICF classification. Int J Rehabil Res (2011) 0.83
Regression of chronic posterior leukoencephalopathy after stop of methotrexate treatment. Neurol Sci (2009) 0.83
Clinical and neuropsychological correlates in two brothers with pantothenate kinase-associated neurodegeneration. Mov Disord (2005) 0.82
Impact of nonmotor symptoms on disability in patients with Parkinson's disease. Int J Rehabil Res (2011) 0.80
Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation. Mech Ageing Dev (2005) 0.80
Charles Bonnet syndrome: two case reports and review of the literature. J Neurol (2013) 0.80
Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease. Parkinsonism Relat Disord (2011) 0.79
Neuroanatomical, Clinical and Cognitive Correlates of Post-Stroke Dysphagia. Eur Neurol (2015) 0.79
Cortical myoclonus in childhood and juvenile onset Huntington's disease. Parkinsonism Relat Disord (2012) 0.79
APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias. Int J Mol Epidemiol Genet (2010) 0.77
Functioning and disability in Parkinson's disease. Disabil Rehabil (2010) 0.77
Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease. Neurol Sci (2008) 0.77
Limb apraxia and cognitive impairment in progressive supranuclear palsy. Neurocase (2005) 0.76
Poststroke fixed dystonia of the foot relieved by chronic stimulation of the posterior limb of the internal capsule. J Neurosurg (2009) 0.76
Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders. Neurol Sci (2012) 0.76
Frequency of DYT1 mutation in early onset primary dystonia in Italian patients. Mov Disord (2002) 0.76
Evaluating voting competence in persons with Alzheimer disease. Int J Alzheimers Dis (2011) 0.75
Psychosocial difficulties in patients with Parkinson's disease. Int J Rehabil Res (2017) 0.75
Deep magnetic stimulation in a progressive supranuclear palsy patient with speech involvement. J Neurol (2012) 0.75
Concordance between severity of disease, prevalence of nonmotor symptoms, patient-reported quality of life and disability and use of medication in Parkinson's disease. Neurol Sci (2011) 0.75
How to assess active contact coordinates in deep brain stimulation surgery? Comparison of three methods for determining the position of the active contact. Stereotact Funct Neurosurg (2010) 0.75
Brain death: what's in a name? Intensive Care Med (2008) 0.75
Plasma cholesterol and Parkinson's disease: is the puzzle only apparent? Mov Disord (2010) 0.75
Levodopa reduces risk factors for vascular disease in parkinsonian patients. J Neurol (2008) 0.75
[Diagnosing Alzheimer's disease: from research to clinical practice and ethics]. Recenti Prog Med (2014) 0.75